Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diffuse in-stent restenosis.

H Störger1

  • 1Red Cross Hospital Cardiology Center, Pfingstweidstr. 11, 60316 Frankfurt, Germany. kardio.centrum@t-online.de

Journal of Interventional Cardiology
|June 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.

Indian heart journal·1998
Same author

[From surgical to interventional standby?].

Zeitschrift fur Kardiologie·1998
Same author

[Balloon angioplasty of stent restenosis: early and late results of first and second PTCA in focal and diffuse stenosis].

Zeitschrift fur Kardiologie·1998
Same author

Results of Micro stent implantations in coronary lesions of various complexity.

The American journal of cardiology·1998
Same author

Randomized comparison of angioplasty of complex coronary lesions at a single center. Excimer Laser, Rotational Atherectomy, and Balloon Angioplasty Comparison (ERBAC) Study.

Circulation·1997
Same author

[Results after coronary bypass operation].

Deutsche medizinische Wochenschrift (1946)·1996
Same journal

Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease.

Journal of interventional cardiology·2024
Same journal

Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.

Journal of interventional cardiology·2024
Same journal

Examining the Outcomes of Hybrid Coronary Revascularization in Acute STEMI Patients from 2015 to 2022.

Journal of interventional cardiology·2024
Same journal

Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.

Journal of interventional cardiology·2024
Same journal

Comparison of Ticagrelor and Clopidogrel in Elective Coronary Stenting: A Double Blind Randomized Clinical Trial.

Journal of interventional cardiology·2024
Same journal

Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends.

Journal of interventional cardiology·2023
See all related articles

Diffuse in-stent restenosis is a challenging problem. Drug-eluting stents show promise for preventing restenosis, offering a potential breakthrough in treatment.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • In-stent restenosis (ISR), particularly diffuse ISR, presents a significant clinical and economic burden.
  • An estimated 250,000 patients developed ISR in 2000, with two-thirds experiencing the difficult-to-treat diffuse pattern.
  • Conventional treatments for ISR yield suboptimal long-term outcomes.

Purpose of the Study:

  • To review the current challenges and emerging therapeutic strategies for in-stent restenosis.
  • To highlight the efficacy of intravascular radiation therapy and advancements in drug-eluting stents.

Main Methods:

  • Review of existing literature on in-stent restenosis treatments.
  • Analysis of outcomes associated with intravascular radiation therapy and drug-eluting stents.

Related Experiment Videos

  • Discussion of recurrence factors and mitigation strategies.

    • Main Results:

    • Intravascular radiation therapy is the sole effective percutaneous treatment for ISR.
    • Improved radiation techniques can minimize geographical miss, a key factor in restenosis recurrence.
    • Early data on drug-eluting stents demonstrate minimal neointimal proliferation, suggesting a significant advancement.

    Conclusions:

    • Diffuse in-stent restenosis remains a difficult clinical problem with high recurrence rates.
    • Intravascular radiation therapy offers an effective percutaneous solution, with technique optimization reducing recurrence.
    • Drug-eluting stents represent a potential breakthrough, showing promise in preventing restenosis.